BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Published:2018-12 Issue:6 Volume:34 Page:879-891
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Merino Delphine,Kelly Gemma L.,Lessene Guillaume,Wei Andrew H.,Roberts Andrew W.,Strasser Andreas

Funder

National Health and Medical Research Council

Cancer Council Victoria

Leukemia Foundation Australia

MCRF

Leukemia & Lymphoma Society Special Center of Research

Medical Research Future

Australian Cancer Research Foundation

Servier

AbbVie

Amgen

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference163 articles.

1. The BCL-2 arbiters of apoptosis and their growing role as cancer targets;Adams;Cell Death Differ.,2018

2. Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia;Aldoss;Haematologica,2018

3. The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism;Anderson;Blood,2016

4. Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage;Arbour;J. Neurosci.,2008

5. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors;Ashkenazi;Nat. Rev. Drug Discov.,2017

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia;Cell Death & Disease;2024-06-12

2. Targeting apoptosis in clear cell renal cell carcinoma;Biomedicine & Pharmacotherapy;2024-06

3. Apoptosis Pathway–Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma;The American Journal of Dermatopathology;2024-05-07

4. Targeted intracellular delivery of BH3 mimetic peptide inhibits BCL-2 activity and prevents breast cancer development;Cancer Insight;2024-04-02

5. Analysis of the Upregulated Expression Mechanism of Apoptotic Chromatin Condensation Inducer 1 in Hepatocellular Carcinoma Based on Bioinformatics;Turkish Journal of Gastroenterology;2024-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3